Kathleen(O'Day)RieweMD

PubMed

• 44 citations
  Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung.
  Alexander J. Chou, Renu Gupta, Moshe D. Bell, Kathleen O.Day Riewe, Paul A. Meyers, Richard Gorlick> ;Pediatric Blood & Cancer. 2013 Apr 1
• Engagement of the T lymphocyte antigen receptor regulates association of son-of-sevenless homologues with the SH3 domain of phospholipase Cgamma1.
  Scholler, J. K., Perez-Villar, J. J., O'Day, K., Kanner, S. B.> ;Eur J Immunol. 2000 Aug
• Nuclear localization of the tyrosine kinase Itk and interaction of its SH3 domain with karyopherin alpha (Rch1alpha).
  Perez-Villar, J. J., O'Day, K., Hewgill, D. H., Nadler, S. G., Kanner, S. B.> ;Int Immunol. 2001 Oct
• Phosphorylation of the linker for activation of T-cells by Itk promotes recruitment of Vav.
  Perez-Villar, J. J., Whitney, G. S., Sitnick, M. T., Dunn, R. J., Venkatesan, S., O'Day, K., Schieven, G. L., Lin, T. A., Kanner, S. B.> ;Biochemistry. 2002 Aug 27
• Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors.
  Das, J., Furch, J. A., Liu, C., Moquin, R. V., Lin, J., Spergel, S. H., McIntyre, K. W., Shuster, D. J., O'Day, K. D., Penhallow, B., Hung, C. Y., Doweyko, A. M., Kama...> ;Bioorg Med Chem Lett. 2006 Jul 15
• Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors.
  Das, J., Liu, C., Moquin, R. V., Lin, J., Furch, J. A., Spergel, S. H., Doweyko, A. M., McIntyre, K. W., Shuster, D. J., O'Day, K. D., Penhallow, B., Hung, C. Y., Kann...> ;Bioorg Med Chem Lett. 2006 May 1
• Selective Itk inhibitors block T-cell activation and murine lung inflammation.
  Lin, T. A., McIntyre, K. W., Das, J., Liu, C., O'Day, K. D., Penhallow, B., Hung, C. Y., Whitney, G. S., Shuster, D. J., Yang, X., Townsend, R., Postelnek, J., Spergel...> ;Biochemistry. 2004 Aug 31
• Join now to see all